A5020605882- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Gastrointestinal Tumor Research and Treatment
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer-related molecular mechanisms research
- Ferroptosis and cancer prognosis
- Lung Cancer Treatments and Mutations
- Intraperitoneal and Appendiceal Malignancies
- MicroRNA in disease regulation
- Ovarian cancer diagnosis and treatment
- Lung Cancer Diagnosis and Treatment
First Hospital of Jilin University
2022-2024
Jilin University
2022-2024
Background: Ulcerative colitis (UC) is a common and progressive inflammatory bowel disease primarily affecting the colon rectum. Prolonged inflammation can lead to colitis-associated colorectal cancer (CAC). While exact cause of UC remains unknown, this study aims investigate role TWIST1 gene in UC. Methods: Second-generation sequencing data from adult patients were obtained Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) identified, characteristic selected...
To investigate the clinical efficacy and safety of albumin paclitaxel combined with intrapleural bevacizumab + lobaplatin for patients non-squamous non-small cell lung cancer (NS-NSCLC) malignant pleural effusion (MPE) analyze prognostic factors. A total 126 NS-NSCLC were included in study. Control group 64 cases received infusion intravenous paclitaxel, treatment 62 additional perfusion. Analysis was performed by collecting data about MPE, progression-free survival (PFS), overall (OS),...